Cellular aspects of Burkholderia cepacia infection (Q34258663)

31 July 2017

1 reference

title

Cellular aspects of Burkholderia cepacia infection (English)

1 reference

31 July 2017

1 reference

C D Mohr

1

1 reference

31 July 2017

M Tomich

series ordinal

2

1 reference

31 July 2017

C A Herfst

series ordinal

3

1 reference

31 July 2017

publication date

1 April 2001

1 reference

31 July 2017

published in

Microbes and Infection

1 reference

31 July 2017

volume

3

1 reference

31 July 2017

issue

5

1 reference

31 July 2017

page(s)

425-435

1 reference

Burkholderia cepacia and cystic fibrosis: do natural environments present a potential hazard?

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901389-2

7 January 2021

Burkholderia cepacia: medical, taxonomic and ecological issues

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901389-2

7 January 2021

Pseudomonas cepacia infection in cystic fibrosis: an emerging problem

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901389-2

7 January 2021

Occurrence of multiple genomovars of Burkholderia cepacia in cystic fibrosis patients and proposal of Burkholderia multivorans sp. nov.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901389-2

7 January 2021

Burkholderia cepacia genomovar VI, a new member of the Burkholderia cepacia complex isolated from cystic fibrosis patients

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901389-2

7 January 2021

Agricultural use of Burkholderia (Pseudomonas) cepacia: a threat to human health?

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901389-2

7 January 2021

Agricultural and medical microbiology: a time for bridging gaps.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901389-2

7 January 2021

Commercial use of Burkholderia cepacia

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901389-2

7 January 2021

Source of Pseudomonas cepacia: ribotyping of isolates from patients and from the environment

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901389-2

7 January 2021

Pathogenicity of microbes associated with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901389-2

7 January 2021

Burkholderia cepacia. Management issues and new insights

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901389-2

7 January 2021

Cystic fibrosis: molecular biology and therapeutic implications

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901389-2

7 January 2021

Evidence for periciliary liquid layer depletion, not abnormal ion composition, in the pathogenesis of cystic fibrosis airways disease

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901389-2

7 January 2021

Type characterisation and antibiotic susceptibility of Burkholderia (Pseudomonas) cepacia isolates from patients with cystic fibrosis in the United Kingdom and the Republic of Ireland

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901389-2

7 January 2021

Pseudomonas cepacia: an emerging pathogen in chronic granulomatous disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901389-2

7 January 2021

Chronic granulomatous disease. Report on a national registry of 368 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901389-2

7 January 2021

Infection with Pseudomonas cepacia in chronic granulomatous disease: role of nonoxidative killing by neutrophils in host defense

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901389-2

7 January 2021

Bacteraemia caused by non-glucose-fermenting gram-negative bacilli and Aeromonas species in patients with haematological malignancies and solid tumours

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901389-2

7 January 2021

Outbreak of Pseudomonas cepacia Bacteremia in Oncology Patients

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901389-2

7 January 2021

Changing epidemiology of infections in patients with neutropenia and cancer: emphasis on gram-positive and resistant bacteria

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901389-2

7 January 2021

Chronic Burkholderia cepacia bronchiectasis in a non-cystic fibrosis individual

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901389-2

7 January 2021

Community-acquired bacteremic Pseudomonas cepacia pneumonia in an immunocompetent host

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901389-2

7 January 2021

Burkholderia (Pseudomonas) cepacia as a cause of brain abscesses secondary to chronic suppurative otitis media

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901389-2

7 January 2021

Foot lesions associated with Pseudomonas cepacia

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901389-2

7 January 2021

Bacterial bronchitis and bronchiectasis in human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901389-2

7 January 2021

Response of Pseudomonas cepacia to beta-Lactam antibiotics: utilization of penicillin G as the carbon source

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901389-2

7 January 2021

Multiple combination bactericidal antibiotic testing for patients with cystic fibrosis infected with Burkholderia cepacia

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901389-2

7 January 2021

Person-to-person transmission of Pseudomonas cepacia between patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901389-2

7 January 2021

The emergence of a highly transmissible lineage of cbl+ Pseudomonas (Burkholderia) cepacia causing CF centre epidemics in North America and Britain

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901389-2

7 January 2021

Evidence for transmission of Pseudomonas cepacia by social contact in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901389-2

7 January 2021

Multiple replicons constituting the genome of Pseudomonas cepacia 17616

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901389-2

7 January 2021

Identification of transposable elements which activate gene expression in Pseudomonas cepacia

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901389-2

7 January 2021

Burkholderia cepacia produces a hemolysin that is capable of inducing apoptosis and degranulation of mammalian phagocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901389-2

7 January 2021

A nonhemolytic phospholipase C from Burkholderia cepacia

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901389-2

7 January 2021

Ornibactin production and transport properties in strains of Burkholderia vietnamiensis and Burkholderia cepacia (formerly Pseudomonas cepacia)

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901389-2

7 January 2021

Production and utilization of pyochelin by clinical isolates of Pseudomonas cepacia.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901389-2

7 January 2021

Isolation of a novel siderophore from Pseudomonas cepacia

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901389-2

7 January 2021

Iron-regulated salicylate synthesis by Pseudomonas spp

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901389-2

7 January 2021

Endotoxic activity of lipopolysaccharides isolated from emergent potential cystic fibrosis pathogens

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901389-2

7 January 2021

Priming of neutrophil respiratory burst activity by lipopolysaccharide from Burkholderia cepacia.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901389-2

7 January 2021

Inhibition of rat alveolar macrophage phagocytic function by a Pseudomonas cepacia lipase

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901389-2

7 January 2021

Quorum sensing in Burkholderia cepacia: identification of the LuxRI homologs CepRI

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901389-2

7 January 2021

Influence of Pseudomonas aeruginosa exoproducts on virulence factor production in Burkholderia cepacia: evidence of interspecies communication

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901389-2

7 January 2021

Cystic fibrosis: inflammatory response to infection with Burkholderia cepacia and Pseudomonas aeruginosa

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901389-2

7 January 2021

Pulmonary function, serum markers of inflammation, and IgG antibodies to core lipopolysaccharide of Burkholderia cepacia in adults with cystic fibrosis, following colonization with Burkholderia cepacia

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901389-2

7 January 2021

Serum IgG antibody to outer membrane antigens of Pseudomonas cepacia and Pseudomonas aeruginosa in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901389-2

7 January 2021

Longitudinal serum IgG response toPseudomonas cepacia surface antigens in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901389-2

7 January 2021

A mouse model of chronic pulmonary infection with Pseudomonas aeruginosa and Pseudomonas cepacia

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901389-2

7 January 2021

Lung disease in the cystic fibrosis mouse exposed to bacterial pathogens

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901389-2

7 January 2021

Pseudomonas aeruginosa and Pseudomonas cepacia isolated from cystic fibrosis patients bind specifically to gangliotetraosylceramide (asialo GM1) and gangliotriaosylceramide (asialo GM2)

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901389-2

7 January 2021

Binding of Pseudomonas cepacia to normal human intestinal mucin and respiratory mucin from patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901389-2

7 January 2021

Differences in eucaryotic cell binding of Pseudomonas

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901389-2

7 January 2021

Identification of the mucin-binding adhesin of Pseudomonas cepacia isolated from patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901389-2

7 January 2021

Cable-piliated Burkholderia cepacia binds to cytokeratin 13 of epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901389-2

7 January 2021

Preferential adherence of cable-piliated burkholderia cepacia to respiratory epithelia of CF knockout mice and human cystic fibrosis lung explants

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901389-2

7 January 2021

Cable (cbl) type II pili of cystic fibrosis-associated Burkholderia (Pseudomonas) cepacia: nucleotide sequence of the cblA major subunit pilin gene and novel morphology of the assembled appendage fibers

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901389-2

7 January 2021

Colonization factors of human enterotoxigenic Escherichia coli (ETEC).

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901389-2

7 January 2021

Structurally variant classes of pilus appendage fibers coexpressed from Burkholderia (Pseudomonas) cepacia

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901389-2

7 January 2021

Pseudomonas cepacia adherence to respiratory epithelial cells is enhanced by Pseudomonas aeruginosa

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901389-2

7 January 2021

Burkholderia (basonym Pseudomonas) cepacia binding to lipid receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901389-2

7 January 2021

Invasion of respiratory epithelial cells by Burkholderia (Pseudomonas) cepacia.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901389-2

7 January 2021

Invasion and intracellular survival of Burkholderia cepacia

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901389-2

7 January 2021

Serum IgG and sputum IgA antibody to core lipopolysaccharide antigen from Pseudomonas cepacia in patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901389-2

7 January 2021

Intracellular survival of Burkholderia cepacia complex isolates in the presence of macrophage cell activation

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901389-2

7 January 2021

Intracellular survival and saprophytic growth of isolates from the Burkholderia cepacia complex in free-living amoebae

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901389-2

7 January 2021

Survival and growth of Burkholderia cepacia within the free-living amoeba Acanthamoeba polyphaga.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901389-2

7 January 2021

An obligately endosymbiotic mycorrhizal fungus itself harbors obligately intracellular bacteria.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901389-2

7 January 2021

Detection and identification of bacterial endosymbionts in arbuscular mycorrhizal fungi belonging to the family Gigasporaceae

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901389-2

7 January 2021

10.1016/S1286-4579(01)01389-2

Identifiers

DOI

1 reference

31 July 2017

1 reference